Mild anxiety and depression have been found in parents or caregivers surrounding children with atopic dermatitis, the most common form of eczema.
In the study presented at the 28th EADV Congress, researchers assessed the impact of an atopic dermatitis diagnosis on the families of 35 children aged 1-6.
They evaluated 83 family members and caregivers and found that all respondents reported at least mild severity anxiety with some showing moderate severity anxiety.
Almost three in four (74 per cent) participants were also found to present with depression.
The study found that depression and anxiety scores were associated with the persistence and longevity of atopic dermatitis. Researchers did not find an association between scores and the severity of the disease, meaning that depression or anxiety was not observed to increase where atopic dermatitis was more severe.
Atopic dermatitis, the most common form of eczema causes the skin to become itchy, red dry and cracked. It is a chronic condition that most often occurs in people who have allergies and can develop alongside asthma and hayfever.
As well as the symptoms of AD, patients with the condition are also known to suffer insomnia, anxiety and psychosocial stress, linked to the physical manifestation of their eczema.
The study utilised the Hamilton Depression Rating Scale (HDRS) and Hamilton Anxiety Rating scale (HAM-A), one of the first and most widely used ratings systems for identifying the two conditions in both a clinical and research setting.
To supplement the ratings questionnaires, the team also asked participants what their greatest concerns were. The most frequent worry reported was the information families and caregivers recieve about the nature of the disease itself, since AD is a long-term condition which requires complex and costly medical treatments.
Lead researcher Dr Vesna Grivcheva-Panovska opined, "The chronicity and complexity of chronic dermatitis often leads to overlooked anxiety and depression in family members and caregivers, but our results show the extent of this cannot be overstated.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
